A May 2026 Andes virus outbreak aboard the Dutch cruise ship MV Hondius, which departed from Argentina, represents a transmission context never before seen in the known epidemiology of the virus. The Andes virus is the only member of the Hantaviridae family capable of efficient person-to-person spread through close contact with respiratory secretions.
The epidemic potential of this pathogen was previously demonstrated during the 2018–19 Epuyén outbreak in Argentina, where four waves of infection from a social gathering resulted in 34 confirmed cases and 11 deaths. The cruise ship environment, with its confined spaces and close quarters, creates ideal conditions for such respiratory transmission.
The Lancet correspondence highlights that this outbreak represents an unprecedented transmission context, though specific case numbers from the cruise ship were not provided in the source. The virus was first described in Argentina, where it remains a significant public health concern.
This event raises urgent questions about screening protocols for cruise passengers and crew, particularly on voyages departing from regions where the virus is endemic. Health authorities may need to reassess preparedness measures for containing person-to-person spread of hantaviruses in confined settings.
The findings underscore the need for continued surveillance and research into single-dose mRNA vaccines against Andes hantavirus, as mentioned in the title of the correspondence. However, the source did not provide further details on vaccine development or efficacy.